欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Niraparib hydrochloride_1038915-64-8_产品详情
1038915-64-8
  • Niraparib hydrochloride

  • names:

    Niraparib hydrochloride

  • CAS号:

    1038915-64-8

    MDL Number:
  • MF(分子式): C19H21ClN4O MW(分子量): 356.85
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Niraparib hydrochloride
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001425-5mg 5mg 99.8% ¥ 1215.00 ¥ 1215.00 2-3天
- +
¥ 0.00
YZM001425-2mg 2mg 99.8% ¥ 858.00 ¥ 858.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 Niraparib hydrochloride
CAS号 1038915-64-8
Inchi
InchiKey
分子式 Formula C19H21ClN4O
分子量 Molecular Weight 356.85
溶解度Solubility 生物体外In Vitro:DMSO溶解度250 mg/mL(700.57 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
产品说明
IntroductionNiraparib hydrochloride (MK827 hydrochloride) is a highly potent and orally bioavailablePARP1andPARP2inhibitor withIC50s of 3.8 and 2.1 nM, respectively. Niraparib hydrochloride (MK827 hydrochloride) leads to inhibition of repair of DNA damage and shows antiumor activity[2][3].
Application1
Application2
Application3
Niraparib hydrochloride (MK-4827 hydrochloride) 是一种有效的,具有口服活性的PARP1和PARP2抑制剂,IC50值分别为 3.8 nM 和 2.1 nM。Niraparib hydrochloride (MK-4827 hydrochloride) 抑制 DNA 损伤修复,并具有抗肿瘤活性。Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailablePARP1andPARP2inhibitor withIC50s of 3.8 and 2.1 nM, respectively. Niraparib hydrochloride (MK-4827 hydrochloride) leads to inhibition of repair of DNA damage and shows anti-tumor activity[1][2][3].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Jones P, et al. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009 Nov 26;52(22):7170-85.
【2】.Bridges KA, et al. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15;5(13):5076-86.
【3】.Wang L, et al. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec;30(6):2113-20.
【4】.Mirza MR, et al. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med. 2016 Dec 1;375(22):2154-2164.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents